Literatur
Bedoui S, Gebhardt T, Gasteiger G, Kastenmüller W (2016) Parallels and differences between innate and adaptive lymphocytes. Nat Immunol 17(5):490–494
Labanieh L, Majzner RG, Mackall CL (2018) Programming CAR-T cells to kill cancer. Nat Biomed Eng 2(6):377–391
Schmidt T, Luebbe J, Paust HJ, Panzer U (2018) Mechanisms and functions of IL-17 signaling in renal autoimmune diseases. Mol Immunol 104:90–99
Houlihan B, Cha P, Zasloff M, Fishbein TM, Kroemer A (2017) An integrated understanding of the immunology of allograft inflammation. Curr Opin Organ Transplant 22(2):155–159
Haouami Y, Dhaouadi T, Sfar I, Bacha M, Gargah T, Bardi R, Abderrahim E, Goucha R, Ben Abdallah T, Gorgi Y (2018) The role of IL-23/IL-17 axis in human kidney allograft rejection. J Leukoc Biol 104(6):1229–1239
Krebs CF, Panzer U (2018) Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases. J Autoimmun 87:61–68
Paust HJ, Turner JE, Steinmetz OM, Peters A, Heymann F, Hölscher C, Wolf G, Kurts C, Mittrücker HW, Stahl RA, Panzer U (2009) The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol 20(5):969–979
Krebs CF, Schmidt T, Riedel JH, Panzer U (2017) T helper type 17 cells in immune-mediated glomerular disease. Nat Rev Nephrol 13(10):647–659
Krebs CF, Paust HJ, Krohn S, Koyro T, Brix SR, Riedel JH, Bartsch P, Wiech T, Meyer-Schwesinger C, Huang J, Fischer N, Busch P, Mittrücker HW, Steinhoff U, Stockinger B, Perez LG, Wenzel UO, Janneck M, Steinmetz OM, Gagliani N, Stahl RAK, Huber S, Turner JE, Panzer U (2016) Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney. Immunity 45(5):1078–1092
Dolff S, Witzke O, Wilde B (2019) Th17 cells in renal inflammation and autoimmunity. Autoimmun Rev 18(2):129–136
Patel DD, Kuchroo VK (2015) Th17 cell pathway in human immunity: Lessons from genetics and therapeutic interventions. Immunity 43(6):1040–1051
Miossec P, Kolls JK (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11(10):763–776
McGeachy MJ, Cua DJ, Gaffen SL (2019) The IL-17 family of cytokines in health and disease. Immunity 50(4):892–906
Satoh Y, Nakano K, Yoshinari H, Nakayamada S, Iwata S, Kubo S, Miyagawa I, Yoshikawa M, Miyazaki Y, Saito K, Tanaka Y (2018) A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab. Lupus 27(7):1202–1206. https://doi.org/10.1177/0961203318762598
Danksagung
Die Autoren danken Herrn PD Dr. Christian F. Krebs, III. Medizinische Klinik und Poliklinik, Universitätsklinikum Hamburg-Eppendorf, für die kritische Durchsicht dieses Beitrags.
Förderung
Die Originalarbeiten der Autoren werden von der Deutschen Forschungsgemeinschaft unterstützt.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Interessenkonflikt
U. Panzer und F. Thaiss geben an, dass kein Interessenkonflikt besteht.
Dieser Artikel ist eine Übersichtsarbeit und enthält daher keine Originaldaten.
Additional information
Redaktion
O. Witzke, Essen
Rights and permissions
About this article
Cite this article
Panzer, U., Thaiss, F. Perspektiven der IL-17/IL-23-Blockade in der Nephrologie und nach Nierentransplantation. Nephrologe 14, 379–383 (2019). https://doi.org/10.1007/s11560-019-0360-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11560-019-0360-9